Modality
Vaccine
MOA
BCL-2i
Target
C5
Pathway
Lipid Met
ETEwing SarcomaCrohn's
Development Pipeline
Preclinical
~Feb 2017
→ ~May 2018
Phase 1
Aug 2018
→ Nov 2028
Phase 1Current
NCT08194507
858 pts·Crohn's
2018-08→2028-11·Not yet recruiting
858 total pts1 indication
Phase 2
Phase 3
NDA/BLA
Approved
CompletedCurrentUpcoming
Catalysts (1)
2028-11-052.6y awayInterim· Crohn's
Trial Timeline
Q3Q42019Q2Q3Q42020Q2Q3Q42021Q2Q3Q42022Q2Q3Q42023Q2Q3Q42024Q2Q3Q42025Q2Q3Q42026Q2Q3Q42027Q2Q3Q42028Q2Q3Q4
P1
Not yet…
Catalysts
Interim
2028-11-05 · 2.6y away
Crohn's
Not yet recruiting|StartCompletionToday
Trials (1)
| NCT | Phase | Indication | Status | N | EP |
|---|---|---|---|---|---|
| NCT08194507 | Phase 1 | Crohn's | Not yet recr... | 858 | DAS28 |
Competitors (10)